Connect with us

Business

Australia to consider EU and UK findings over AstraZeneca Covid vaccine and blood clots – The Guardian

Review follows a UK decision to offer people under 30 an alternative jab following formal link to rare blood clots

Published

on

Vaccines and immunisation
Australian authorities will review the findings of British and European regulators over concerns about the AstraZeneca Covid-19 vaccine but continue to emphasise that the benefits outweigh the risks.
The review follows a decision in the United Kingdom to offer healthy adults aged under 30 an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.
The European Medicines Agency also announced on Wednesday that the rare blood clots would be listed…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
2 rapidly growing ASX shares to buy – The Motley Fool Australia
2 rapidly growing ASX shares to buy